18+5! Guangzhou Women and Children's Medical Center Achieves New Breakthrough in Clinical High-Tech, Major and Specialty Technology Projects

Background

The Guangzhou Health Commission announced the list of clinical high-tech, major and specialty technology projects for the 2026-2028 period. Guangzhou Women and Children's Medical Center had five additional projects selected in this round. This brings the hospital's cumulative total of such approved projects to 23.

The hospital has focused on advancing frontier technology applications and strengthening specialty capabilities in pediatric and women's health. These approvals support the construction of a clinical technology highland and first-class medical disciplines. The projects target improvements in diagnosis and treatment of complex and critical conditions in children, including advanced cardiac care.

What was achieved

Among the approvals is a major project on the construction and application of a full-process quality improvement and precision diagnosis and treatment system for pediatric heart transplantation. The center obtained qualification for pediatric heart transplantation in 2024 and had completed 16 such procedures by the time of the announcement. The project involves a multidisciplinary team covering cardiac surgery, cardiovascular medicine, intensive care, anesthesia, extracorporeal circulation and nursing. It spans pre-transplant evaluation through postoperative management.

A specialty technology project covers the application of autologous right atrial appendage in pulmonary valve reconstruction. The center has applied this approach in 30 cases since 2023, reported as a national leader. The technique is used for right ventricular outflow tract reconstruction in complex congenital heart disease. Outcomes include low complication rates and a reintervention rate of zero. These projects, along with others approved, contribute to broader progress in managing complex critical pediatric illnesses. The hospital's cumulative 23 approved clinical high-tech, major and specialty technology projects reflect sustained advancement in these areas.

How it works

Pediatric heart transplantation involves replacing a failing heart in a child with a donor heart. The approved quality improvement system establishes standardized protocols across multiple specialties. This includes careful assessment of recipients before transplant, donor organ management, the surgical procedure itself, and comprehensive follow-up care. Specific metrics reported for the cases include an average donor cold ischemia time of 234.5 minutes and recipient aortic cross-clamp time of 57.5 minutes, with donor-to-recipient weight ratios kept below 1.4. The multidisciplinary approach aims to optimize each stage, improve precision, and enhance overall outcomes through coordinated care and data-driven practices.

In certain complex congenital heart defects, the right ventricular outflow tract and pulmonary valve require reconstruction to restore proper blood flow from the heart to the lungs. Traditional options may use artificial valves or donor tissue that do not grow with the child, potentially leading to leakage (regurgitation), narrowing (stenosis), or the need for additional operations as the patient develops. The autologous right atrial appendage technique uses the patient's own tissue from the right atrial appendage—a small, pouch-like part of the heart that can be harvested and reshaped. Surgeons fashion this living tissue into a bicuspid (two-leaflet) valve. Because it is the patient's own tissue, it has the potential to grow along with the child, integrate naturally, and reduce long-term complications such as valve dysfunction and repeat surgeries.

What it means for international patients

The hospital serves a regional and national patient base, with approximately 30 percent of patients coming from outside Guangdong province. It maintains an international medical department and English-language support. It has established collaborations with overseas institutions including children's hospitals in the United States. These developments in pediatric cardiac care, particularly in heart transplantation systems and innovative valve reconstruction for congenital heart disease, signal capacity in managing complex cases.

International patients considering care for pediatric heart conditions at the center should confirm current availability, specific eligibility criteria, and any requirements for these or related services directly with the hospital. Suitability depends on individual medical circumstances, regulatory approvals, and the hospital's ongoing programs. The hospital's designation as a national center may facilitate access for patients from across China and abroad, but direct verification remains necessary.

About the hospital

Guangzhou Women and Children's Medical Center, also known as Guangzhou Medical University Affiliated Women and Children's Medical Center, is a public tertiary Grade A specialty hospital located in Guangzhou, China. It integrates services from the former Guangzhou Children's Hospital, Guangzhou Women and Infants Hospital, and Guangzhou Maternal and Child Health Care Hospital. The center has been designated as a National Children's Medical Center and serves as a national regional medical center construction output unit for Central South China. It operates five campuses in central Guangzhou with a total of approximately 2,400 approved beds.

The hospital maintains eight national clinical key specialties and 13 provincial clinical key specialties. It is a national-level unit for integrated fetal heart disease mother-fetus medicine management and for multidisciplinary collaboration in maternal care. According to Fudan University hospital rankings, its pediatric surgery ranks fourth nationally and pediatric internal medicine ranks eighth. In 2025, the center recorded 4.89 million outpatient and emergency visits, 167,000 discharges, 120,000 surgeries, and 30,000 deliveries. It has performed pediatric heart transplants, ranking first among children's specialty hospitals in China for volume, along with other advanced procedures such as robotic surgery, hematopoietic stem cell transplantation, and ECMO support. The center also conducts substantial research, with hundreds of National Natural Science Foundation of China grants.